MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202611099045 A) filed by Chitkara University on August 17, 2026, for Nanoemulgel Composition Comprising Rosuvastatin And Quercetin For Topical Wound Therapy, And Method Of Preparation Thereof.
Inventors include Sweta Ravindra Singh; Raj Kamal; Dr. Ankit Awasthi; Dr. Thakur Gurjeet Singh; and Dr. Sonia Dhiman.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The present invention provides a pharmaceutical nanoemulgel composition comprising a synergistic combination of rosuvastatin and quercetin, formulated using an oil phase, a surfactant, a co-surfactant, and an aqueous phase, the nanoemulsion so formed being incorporated into a gel base, to achieve a nanoscale globule size, a low polydispersity index, and a high drug-loading efficiency for both active agents. The composition exhibits enhanced skin permeation, a biphasic and sustained in vitro drug release profile, and prolonged retention at the site of application, rendering it suitable for the topical management of chronic wounds. The invention also provides a process for the preparation of the said nanoemulgel composition.
Disclaimer: Curated by HT Syndication.
